Simiso Sokhela
15PUBLICATIONS
89CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 02, 2025
The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis.Rephaim Mpofu, Nomathemba Chandiwana, Simiso Sokhela
|Nov 07, 2025
Pulmonary manifestations of long COVID in Johannesburg, South Africa.Charles Feldman, Ncomeka Manentsa, Godspower Akpomiemie
|Nov 04, 2025
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial.Cissy Kityo, Ivan K Mambule, Joseph Musaazi
|Apr 04, 2025
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid.Jessica Taylor, Gary Maartens, Simiso Sokhela
|Mar 13, 2025
Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial.Jürgen K Rockstroh, Roger Paredes, Pedro Cahn
|Jul 19, 2024
Low CD4 counts predict excessive weight gains during first-line treatment for HIV.Andrew Hill, Tamara Tovar Sanchez, Eric Delaporte
Pageof 3
Frequent Collaborators
11 joint publications
Willem Daniel Francois Venter
6 joint publications
Nomathemba Chandiwana
6 joint publications
Gary Maartens
5 joint publications
Phumla Z Sinxadi
4 joint publications
Lubbe Wiesner
4 joint publications
Godspower Akpomiemie
3 joint publications
Michelle Moorhouse
3 joint publications
Paolo Denti
2 joint publications
Rephaim Mpofu
2 joint publications
Roeland E Wasmann
